Beta-Adrenergic Agents Short-Acting (Inhaled)

Beta-adrenergic agents, short-acting (inhaled)—commonly referred to as inhaled short-acting beta-agonists (SABAs)—are a class of rapid-acting bronchodilators administered via inhalation These medications selectively stimulate beta-2 adrenergic receptors on airway smooth muscle, prompting intracellular cyclic adenosine monophosphate (cAMP) production that results in smooth muscle relaxation and prompt airway dilation

Beta-adrenergic agents, short-acting (inhaled)—commonly referred to as inhaled short-acting beta-agonists (SABAs)—are a class of rapid-acting bronchodilators administered via inhalation Functioning primarily as quick-relief or rescue therapy, they are indicated for the acute relief of reversible bronchospasm and the prevention of exercise-induced bronchospasm in obstructive respiratory diseases, predominantly asthma and chronic obstructive pulmonary disease (COPD)

These medications selectively stimulate beta-2 adrenergic receptors on airway smooth muscle, prompting intracellular cyclic adenosine monophosphate (cAMP) production that results in smooth muscle relaxation and prompt airway dilation Functioning primarily as quick-relief or rescue therapy, they are indicated for the acute relief of reversible bronchospasm and the prevention of exercise-induced bronchospasm in obstructive respiratory diseases, predominantly asthma and chronic obstructive pulmonar...

Functioning primarily as quick-relief or rescue therapy, they are indicated for the acute relief of reversible bronchospasm and the prevention of exercise-induced bronchospasm in obstructive respiratory diseases, predominantly asthma and chronic obstructive pulmonary disease (COPD)